Daniel Laser,, Ph.D., Wave 80’s CEO and President, will give an invited talk at the 39th Annual Oak Ridge conference: Harnessing New Technology for Clinical Diagnostics. The work to be reported includes significant contributions from Wave 80 immunoassays lead Dr. Ian Gibbons.
The annual Oak Ridge meeting is sponsored by American Association for Clinical Chemistry and brings together thought leaders in diagnostics methods and instrumentation. The 2007 meeting will be held in St. Louis, Missouri on April 18-19, 2007.
Related Posts
